11β-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction

Human Reproduction

Volumn 13, Issue 4, 1998, Pages 799-804

  Shams, M ^a   Kilby, M D ^a   Somerset, D A ^a   Howie, A J ^a   Gupta, A ^a   Wood, P J ^b   Afnan, M ^a   Stewart, P M ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase; Cortisol; Cortisone; Fetal growth; Placenta

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; GLUCOCORTICOID; HYDROCORTISONE; ISOENZYME; PLACENTA ENZYME; HYDROXYSTEROID DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNOCYTOCHEMISTRY; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; NORMAL HUMAN; PLACENTA; PLACENTA DEVELOPMENT; PLACENTA WEIGHT; PREGNANCY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; UMBILICAL ARTERY; UMBILICAL VEIN; BLOOD; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; LABOR; METABOLISM; REFERENCE VALUE; VASCULARIZATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LABOR, OBSTETRIC; PLACENTA; PREGNANCY; PREGNANCY TRIMESTERS; REFERENCE VALUES; UMBILICAL ARTERIES;

EID: 0031596094     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.4.799     Document Type: Article

References (44)

1. Albiston, A.L., Obeyesekere,V.R., Smith, R.E. and Krozowski, Z.S. (1994) Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol., 105, R11-R17.
2. Baggia, S., Albrecht, E.D. and Pepe, J.G. (1990) Regulation of 11β- hydroxysteroid dehydrogenase activity in the baboon placenta by estrogen. Endocrinology, 126, 2742-2748.
3. Barker, D.J.P., Bull, A.R., Osmond, C. and Simmonds, S.J. (1990) Fetal and placental size and risk of hypertension in adult life. Br. Med. J., 301, 259-262.
4. Benediktsson, R., Lindsay, R.S., Noble, J. et al. (1993) Glucocorticoid exposure in utero: new model for adult hypertension. Lancet, 341, 339-341.
5. Benediktsson, R., Calder, A.A., Edwards, C.R.W. and Seckl, J.R. (1997) Placental 11β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin. Endocrinol., 46, 161-166.
6. Blasco, M.J., Lopez-Bernal, A. and Turnbull, A.C. (1986) 11β-hydroxysteroid dehydrogenase activity of the human placenta during pregnancy. Horm. Metab. Res., 18, 638-641.
7. Bro-Rasmussen, F., Buus, O. and Trolle, D. (1962) Ratio of cortisone/cortisol in mother and infant at birth. Acta Endocrinol., 40, 579-583.
8. Brown, R.W., Chapman, K.E., Edwards, C.R.W. and Seckl, J.R. (1993) Human placental 11β-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD dependent isoform. Endocrinology, 132, 2614-26120.
9. Brown, R.W., Diaz, R., Robson, A.C. et al. (1996) The ontogeny of 11β- hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology, 137, 794-797.
10. Bujalska, L. Shimojo, M., Howie, A.J. and Stewart, P.M. (1997) Human 11β- hydroxysteroid dehydrogenase: Studies on the expressed isoform and localization of the type 2 isozyme within renal tissue. Steroids, 62, 77-82.
11. Chang, T.C., Rosson, S.C. and Spencer, J.A.D (1993) Identification of fetal growth restriction: comparison of Doppler waveform indices and measurements of abdominal circumference and fetal weight. Obstet. Gynaecol., 82, 230-236.
12. Condon, J., Ricketts, M.L., Whorwood, C.B. and Stewart, P.M. (1997) Ontogeny and sexual dimorphic expression of mouse type 2 11β- hydroxysteroid dehydrogenase. Mol. Cell. Endocrinol., 127, 121-128.
13. Goland, R.S., Jozak, S., Warren, W.B. et al. (1993) Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth retarded fetuses. J. Clin. Endocrinol. Metab., 77, 1174-1179.
14. Hales, C.N., Barker, D.J.P., Clark, P.M.S. et al. (1991) Fetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J., 303, 1019-1022.
15. Jackson, M.R., Walsh, A.J., Morrow, R.J. et al. (1995) Reduced placental villous tree elaboration in small-for-gestational age pregnancies; relationship with umbilical artery Doppler waveforms. Am. J. Obstet. Gynecol., 172, 518-522.
16. Khong, T.V., De Wolf, F., Robertson, W.B. and Brosens, I.A. (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and fetal growth restriction. Br. J. Obstet. Gynaecol., 93, 1049-1059.
17. Kitanaka, S., Tanae, A. and Hibi, I. (1996) Apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase deficiency: a possible cause of intrauterine growth retardation. Clin. Endocrinol., 44, 353-359.
18. Krozowski, Z., Maguire, J.A., Stein-Oakley, A.N. et al. (1995) Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J. Clin. Endocrinol. Metab., 80, 2203-2208.
19. Law, C.M. and Barker, D.J.P. (1994) Fetal influence on blood pressure. J. Hypertension, 12, 1329-1332.
20. Lindsay, S.R., Lindsay, M.R., Edwards, C.R.W. and Seckl, R.J. (1995) Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and programming of blood pressure in the offspring. Hypertension, 27, 1200- 1204.
21. Lopez-Bernal, A., Flint, A.P.F., Anderson, A.B.M. and Turnbull, A.C. (1980) 11β-hydroxysteroid dehydrogenase activity in human placenta and decidua. J. Steroid Biochem., 13, 1081-1087.
22. Lopez-Bernal, A., Anderson, A.B.M. and Turnbull A.C. (1982) The lack of influence of labor on human placental 11β-hydroxysteroid dehydrogenase activity. J. Clin. Endocrinol. Metab., 54, 1251-1254.
23. Moore, A. Aitken, R., Burke, C. et al. (1985) Cortisol assay guidelines for the provision of a clinical biochemistry service. Ann. Clin. Biochem., 22, 435-454.
24. Murphy, B.E., Clark, S.J., Donald, I.R. et al. (1974) Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am. J. Obstet. Gynecol., 118, 538-541.
25. Novy, J.M. and Walsh, S.W. (1983) Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones and fetal growth. Am. J. Obstet. Gynecol., 145, 920-931.
26. Pepe, G.J. and Albrecht, E.D. (1995) Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr. Rev., 16, 608-648.
27. Pepe, G.J., Jeffrey, B.S., Burch, M.G. et al. (1996) Developmental increase in expression of the messenger ribonucleic acid and protein levels of 11β- hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta. Endocrinology, 137, 5678-5684.
28. Pijnenborg, R. (1996) The placental bed. Hypertension Pregn., 15, 7-23.
29. Reinisch, J., Simon, N.G. and Karow, W.G. (1978) Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science, 202, 436-438.
30. Riley, S.C., Walton, J.C., Herlick, J.M. and Challis, J.R.G. (1991) The localization and distribution of corticotropin-releasing hormone in the human placenta and fetal membranes throughout gestation. J. Clin. Endocrinol. Metab., 72, 1001-1007.
31. Rogerson, P.M., Kayes, K.M. and White, P.C. (1997) Variation in placental type 2 11β-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol. Cell. Endocrinol., 128, 103-109.
32. Shimojo, M., Ricketts, M.L., Massimiliano, P.D. et al. (1997) Immunodetection of 11β-hydroxysteroid type 2 in human mineralocorticoid target tissues: evidence for nuclear localization. Endocrinology, 138, 1305-1311.
33. Stewart, P.M. (1996) 11β-hydroxysteroid dehydrogenase: implications for clinical medicine. Clin Endocrinol, 44, 493-499.
34. Stewart, P.M., Come, J.E., Shackleton, C.H. and Edwards, C.R.W. (1988) Syndrome of apparent mineralocorticoid excess. A defect in the cortisolcortisone shuttle. J. Clin. Invest., 82, 340-349.
35. Stewart, P.M., Murry, B.A. and Mason, J.I. (1994a) Human kidney 11β- hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type 1 isoform. J. Clin. Endocrinol. Metab., 79, 480-484.
36. Stewart, P.M., Murry, B.A. and Mason, J.I. (1994b) Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab, 78, 1529-1532.
37. Stewart, P.M., Rogerson, F.M. and Mason, J.I. (1995) Type 2 11β- hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: Its relationship to birthweight and putative role in fetal adrenal steroidogenesis. J. Clin. Endocrinol. Metab., 80, 885-890.
38. Stewart, P.M., Krozowski, Z.S., Gupta, A. et al. (1996) Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β- hydroxysteroid dehydrogenase type 2 gene. Lancet, 347, 88-91.
39. Sun, K., Yang, K. and Challis, J.R.G. (1997) Differential expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes. Endocrinology, 82, 300-305.
40. Tannin, G.M., Agarwal, A.K., Monder, C. et al. (1991) The human gene for 11β-hydroxysteroid dehydrogenase. J. Biol. Chem., 266, 16653-16658.
41. West Midlands Perinatal Audit (1996) Confidential Enquiry into Stillbirth and Neonatal Death: 1991-1994. A Report of National, Regional and District Mortality Rates. West Midlands Perinatal Audit.
42. White, P.C., Mune, T. and Agarwal, A.K. (1997) 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr. Rev., 18, 135-156.
43. Whorwood, C.B., Mason, J.I., Ricketts, M.L. et al. (1995) Detection of human 11β-hydroxysteroid dehydrogenase isoforms using RT-PCR and localization of the type 2 isoform to renal collecting ducts. Mol. Cell. Endocrinol., 110, R7-R12.
44. Wood, P.J., Glen, C. and Donovan, S.J. (1996) A simple RIA for serum cortisone without preliminary steroid chromatography. J. Endocrinol., 148S, 317.